Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by toolmantayloron Dec 07, 2016 2:33pm
152 Views
Post# 25567421

Cannot argue these points at least.

Cannot argue these points at least.)  First, here is the exact wording of the warrants:

$23 Million Brokered Private Placement On August 17, 2016, the Company closed a brokered private placement of 57,500,000 subscription receipts for aggregate gross proceeds of $23,000,000. Each subscription receipt was converted into units of the Company upon the satisfaction of the conditions precedent to the acquisition of CanvasRx Inc. Each unit consisted of one common share and one-half of one common share purchase warrant of the Company. Each whole warrant entitles the holder to purchase an additional common share at an exercise price of $0.55 per share expiring August 9, 2018. A portion of the net proceeds from the Offering was used to satisfy the cash component of the acquisition.

2) Fist falsehood:  There are NOT 57.5 million shares flooding the market.  Each subscription receipt can be converted into 1/2 warrant.  And then each FULL warrant (2 half warrants) can be converted into a share.  That means that there will be 1/2 of 57.5 million, which is 28.75 million shares.

3) Second Falsehood:  These shares will be flooding the market?  At all?  Complete lie.  The warrants only give the OPTION to PURCHASE shares, and this option must be excercised by AUGUST 9th 2018...ALMOST 2 YEARS AWAY!  Now why on earth would you exercise them now?  The answer is, you wouldn't.  We all know the company is worth vastly more 2 years down the road.  So the warrant holders will just sit on their goldmine, and sell down the road. They would be IDIOTS to sell now.  Would they sell now?  No, they won't. Completely fabricated.

4) 3rd Falsehood:  These warrants are somehow going to dilute the total share count. COMPLETELY FALSE!  People, the shares are ALREADY ACCOUNTED FOR.  57 million shares, plus 1/2 57.5 Million (warrants), which is 28.75 Million = a total of 86,250,000

THESE SHARES ARE NOT GOING TO BE ADDED. THEY ARE ALREADY IN.

Take a look at the share count from any news release:

For example: On July 28th, the share count was 135Million (and change).

Then, after the Rx aquisition take a look at the release on September 6th.  The share count is now 231 Million.  There were a couole of other small deals in there which is why the math is not perfect here.  BUT:

THE DILLUTION HAS ALREADY BEEN ACCOUNTED FOR, AND TO SAY MASSIVE DILLUTION IS COMING IS A COMPLETE LIE.

You want a freakin' awesome buying opportunity??  ITS THERE.

And to all the dummass bashers, your false statements are now completely blown out of the water.  Frig, it's like shooting fish out of a barrell. ;)

Read more at https://www.stockhouse.com/companies/bullboard?symbol=v.acb&postid=25563783#r4pWIpKSD0eT0YhO.99

 Credit: Starsearcher40


Until I see Mike or these "righteous" guys argue these points this is the buying op they are talking about.
Bullboard Posts